Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.19ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-14696.5South Korea
BA.1.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-14678.7South Korea
B.1.1.239NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14673.5Hong Kong
BA.2.24SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-14660.3Japan
B.1.432ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-14642.7Germany
BA.5.5.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-14642.7Germany
HK.21NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14622Hong Kong
BA.2.16NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14622Hong Kong
B.1.160.13NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14622Hong Kong
B.12NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14622Hong Kong
XBB.1.28.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14622Hong Kong
AY.112.3 (Delta)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-14610.8France
EG.5.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-14595.2Japan
BA.5.2.49ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-14595.2Japan
B.1.258.17NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-14584.6US
BA.2.76NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-14576.8Hong Kong
B.1.77NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-14566Japan
A.29NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-14560.2Thailand
B.1.357ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
L.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
BQ.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
EG.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
LB.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.258ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.1.437NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-14547China
B.1.1.391ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-14522.5Hong Kong
B.1.151ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-14522.5Hong Kong
LF.3.1.1ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-14518.2Hong Kong
XBB.1.41.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
B.1.177.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
B.1.1.163SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
B.1.287SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
B.1.1.428SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
B.1.36.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
AY.4.13 (Delta)NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-14490.6US
B.1.173SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-14485.7South Korea
B.1.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-14479.3Singapore
B.1.596.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-14479.3Singapore
JD.2.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.1.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.1.5ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.1.8ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.2.2ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.1.3ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.1.7ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
KK.2ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
KK.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
JD.1.2.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-14403.2France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used